Filing Flows › Prime Medicine (PRME) › Recalls, complaints & regulation
Prime Medicine (PRME): clinical trials
Prime Medicine (PRME) beyond its filings: 4 active clinical trials.
Prime Medicine's latest quarter
Prime Medicine, Q4 2025: revenue $838K (-62% year over year), net loss $46.1M, operating cash flow −$37.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Prime Medicine have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.